Exelixis Announces Acceptance Of New Drug Application For Combo To Treat Rare Melanoma
February 20, 2015 at 12:10 PM EST
Exelixis and Roche announce that FDA accepted NDA for For Cobimetinib Together With VemuraFenib to treat a rare type of skin cancer.
